Daiwa Securities Group
HALO icon

Daiwa Securities Group’s Halozyme HALO Stock Holding History

Daiwa Securities Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21
Closed -$1K – 1327
2023
Q4 		$1K Buy
+21
New +$791 ﹤0.01% 1296

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Daiwa Securities Group's HALO Position: Q2 2026 in Review

Daiwa Securities Group increased its Halozyme (HALO) stake by 12% in Q2 2026, buying an estimated $184K and bringing the position to 25,700 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Daiwa Securities Group first reported a position in HALO in Q1 2018 and has held it in 34 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Daiwa Securities Group held 25,700 shares of Halozyme worth $2.01M as of Q2 2026.
  • Daiwa Securities Group bought 2,700 Halozyme shares in Q2 2026, an estimated $184K.
  • Halozyme made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #691 holding.
  • Daiwa Securities Group first reported a position in Halozyme in Q1 2018 and has held it in 34 quarters since.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.